Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review. (Q36532395)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

review article

1 reference

title

Bisphosphonate-associated osteonecrosis of the jaws. Report of a case and literature review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

Eliete Neves Silva Guerra

26 December 2019

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Paulo Tadeu Figueiredo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Nilce Santos Melo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ana Carolina Acevedo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Marcelo Gusmão Paraíso Cavalcanti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Lílian Marly Paula

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ana Patrícia Paula

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

20 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

14-21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16831667%20AND%20SRC:MED&resulttype=core&format=json

Intravenous bisphosphonates and osteonecrosis

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

7 January 2021

Osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Bisphosphonates induce apoptosis in human myeloma cell lines: a novel anti-tumour activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis of the jaws: a complication of cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis of the jaws associated with cancer chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis of the jaw associated with zoledronate therapy in a patient with multiple myeloma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Jaw avascular bone necrosis associated with long-term use of biphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

[Bisphosphonates and osteonecrosis of the jaw]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis of the jaw and bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteonecrosis and bisphosphonates: correlation versus causation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Bisphosphonates and bone necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Alternative bisphosphonate targets and mechanisms of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045

Osteomyelitis of the maxilla secondary to osteopetrosis: report of a case.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2005.10.045